AcelRx Pharmaceuticals' ARX-04 Final Stage Study Meets Primary Endpoint By: Benzinga via Benzinga August 15, 2016 at 08:11 AM EDT AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) disclosed top line results of its ARX-04 final stage study, which met its primary ... Read More >> Related Stocks: Acelrx Pharmaceutica